Records containing: Prognostic Stage IIIC Breast Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-30A Phase-2, Two-Cohort Trial of Neoadjuvant Nab-Paclitaxel and Alpelisib in Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations
-
CLINICAL_TRIALS study record update · 2025-08-20Safely Stopping Pre-Medications in Patients Receiving Paclitaxel: A Randomized Trial
-
CLINICAL_TRIALS study record update · 2025-08-07Phase II Trial of Rifaximin in Patients With Early Stage HER2 Positive Breast Cancer With Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy
-
CLINICAL_TRIALS study record update · 2025-08-01Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors
-
CLINICAL_TRIALS study record update · 2025-08-01Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-29A Phase Ib Study of the Safety and Pharmacology of Nilotinib to Prevent Paclitaxel-Induced Peripheral Neuropathy in Patients With Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-06-17THRIVE Smart - Leveraging Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-05-21A Phase 1b Study of Talimogene Laherparepvec (T-VEC) in Combination With Chemotherapy or Endocrine Therapy in Patients With Metastatic, Unresectable, or Locoregionally Recurrent HER2-negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-05-13A Phase 1B Trial Evaluating the Safety of Ribociclib, Tucatinib, and Trastuzumab in Patients With Metastatic, HER2+ Breast Cancer and a Multicenter, Randomized, Open-Label, Phase 2 Study of Preoperative Treatment With Ribociclib,Ttrastuzumab, Tucatinib, and Fulvestrant Versus Docetaxel, Carboplatin,Ttrastuzumab, and Pertuzumab in HR+/HER2+ Breast Cancer and Ribociclib, Trastuzumab, and Tucatinib Versus Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab in Patients With HR-/HER2+ Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-04-29Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-04-24Single-Institution Trial Investigating the Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in Taxane Induced Peripheral Neuropathy (CIPN) in Patients With Early Stage Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-04-02Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)
-
CLINICAL_TRIALS study record update · 2025-03-25Supporting Black Breast Cancer Survivors: Feasibility Trial of Health Coaching-Based Navigation at the Conclusion of Treatment
-
CLINICAL_TRIALS study record update · 2025-02-25Phi29 Motor Nanopore for Single Molecule Sensing: Breast Nipple Aspirate Fluid
-
CLINICAL_TRIALS study record update · 2025-02-17Phase I/II Safety and Efficacy Study of Autophagy Inhibition With Hydroxychloroquine to Augment the Antiproliferative and Biological Effects of Pre-Operative Palbociclib Plus Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-02-07Episodic Future Thinking: An Interventional Pilot Study to Promote Weight Loss in Breast Cancer Survivors
-
CLINICAL_TRIALS study record update · 2025-01-28Pharmacodynamic Study of Estrogen Suppression Threshold-Directed Therapy (ESTDT) of Anastrozole as Adjuvant Therapy for Early Stage Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-10-24Enhancing Immunotherapy by Targeting the EGFR Pathway in Inflammatory Breast Cancer: A Phase II Study of Panitumumab (PmAb) and Pembrolizumab (Pembro) in Combination With Neoadjuvant Chemotherapy (NAC) in Patients With Newly Diagnosed Triple Negative Inflammatory Breast Cancer (TN-IBC)
-
CLINICAL_TRIALS study record update · 2024-10-22A Pilot Single Arm Open Label Trial Evaluating M7824 (Anti-PD-L1/TGF-Beta TRAP) in a Window Setting in Patients With Stage II-III HER2/Neu Positive (HER2+) Breast Cancer (BC)
-
CLINICAL_TRIALS study record update · 2024-10-10Phase Ib Study of BYL719 (Alpelisib) in Combination With Androgen Receptor Inhibitor (Enzalutamide) in Patients With Androgen Receptor (AR)-Positive and PTEN Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-10-02Atorvastatin in Triple-Negative Breast Cancer (TNBC) Patients Who Did Not Achieve a Pathologic Complete Response (pCR) After Receiving Neoadjuvant Chemotherapy, a Multicenter Pilot Study
-
CLINICAL_TRIALS study record update · 2024-08-26Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
-
CLINICAL_TRIALS study record update · 2024-08-14Precision Pharmacogenomics in Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-06-12Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women
-
CLINICAL_TRIALS study record update · 2024-06-10A Mobile TXT-Based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors